Low-quality Trials as a Source of Heterogeneity in the Association of Hydroxyethyl Starch 130/0.4 or 0.42 with Excess Mortality in Sepsis.

Author: Christian J WIEDERMANN ¹
Author Information

1. Department of Internal Medicine, Central Hospital of Bolzano/Bozen, Bolzano/Bozen (BZ), Italy.
Publication Type:Letter
MeSH: Humans; Hydroxyethyl Starch Derivatives; therapeutic use; Sepsis; mortality; therapy
From: Chinese Medical Journal 2016;129(1):116-117
CountryChina
Language:English